MWNA
OM icon

Marshall Wace North America’s Outset Medical OM Stock Holding History

Marshall Wace North America’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1M Buy
+1,354
New +$923K ﹤0.01% 917
2021
Q2 		– Sell
-2,009
Closed -$1.64M – 1668
2021
Q1 		$1.64M Sell
2,009
-257
-11% -$198K 0.01% 885
2020
Q4 		$1.93M Buy
2,266
+1,240
+121% +$956K 0.01% 765
2020
Q3 		$769K Buy
+1,026
New +$843K ﹤0.01% 873

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Marshall Wace North America's OM Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Outset Medical (OM) in Q3 2021: 1,354 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #917 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in OM as recently as Q1 2021.

Marshall Wace North America first reported a position in OM in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.93M in Q4 2020. 142 funds tracked by Wall St. Rank hold OM as of Q3 2021.

  • Marshall Wace North America held 1,354 shares of Outset Medical worth $1M as of Q3 2021.
  • Outset Medical was a new Marshall Wace North America position in Q3 2021.
  • Outset Medical made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #917 holding.
  • Marshall Wace North America first reported a position in Outset Medical in Q3 2020 and has held it in 4 quarters since.
  • Marshall Wace North America's Outset Medical position peaked at $1.93M in Q4 2020.
  • 142 funds tracked by Wall St. Rank held Outset Medical as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.